Pain Drug Co. Insys Faces Stock-Drop Suit After Audit News
Insys Therapeutics Inc., a publicly traded company that sells and develops pain treatments for people with cancer and epilepsy, was hit with a potential securities fraud class action in New York...To view the full article, register now.
Already a subscriber? Click here to view full article